Skip to main content

Table 1 Correlations of both PDGF-BB and VEGF-C coexpression with clinicopathological factors in primary human NSCLC

From: Overexpression of both platelet-derived growth factor-BB and vascular endothelial growth factor-C and its association with lymphangiogenesis in primary human non-small cell lung cancer

 

Factors

P + V+

P-V-

P1

P + V -

P2

P-V+

P3

Gender

Male

35

13

0.476

16

0.716

14

0.847

 

Female

17

4

 

5

 

5

 

Age

>60 years

23

11

0.047

13

0.859

11

0.676

 

≤60 years

29

6

 

8

 

8

 

Histology

SQC

28

6

0.184

6

0.539

5

0.559

 

ADC

24

11

 

15

 

14

 

Tumor size

>5 cm

24

3

0.037

5

0.950

6

0.563

 

≤5 cm

28

14

 

16

 

13

 

differentiation

WD, MD

35

17

0.017

17

0.757

12

0.027

 

PD

17

0

 

4

 

7

 

TNM stage

I-IIa

12

8

0.113

10

0.973

8

0.765

 

IIb-III

40

9

 

11

 

11

 

Nodal status

Positive

29

3

0.006

5

0.471

7

0.362

 

Negative

23

14

 

14

 

12

 
  1. Note: P1, P value between P + V + and P-V-; P2 , P value between P + V- and P-V-; P3, P value between P-V + and P-V-.
  2. Abbreviations: WD well differentiated, MD moderately differentiated, PD poorly differentiated, ADC adenocarcinoma, SQC squamous cell carcinoma.